{
 "drug": "Hydrochlorothiazide Capsule",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "11/19/2025",
 "dayN": 279,
 "cat": "Cardiovascular",
 "companies": [
  "Teva Pharmaceuticals USA, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "11/19/2025",
   "update_type": "New",
   "initial_posting_date": "11/19/2025",
   "package_ndc": "0591-0347-01",
   "generic_name": "Hydrochlorothiazide Capsule",
   "contact_info": "800-545-8800",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA020504"
    ],
    "brand_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-0347"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "199903"
    ],
    "spl_id": [
     "b062bc7e-af92-4648-aed1-e02568313e21"
    ],
    "spl_set_id": [
     "a3eb7294-f913-434b-896c-da028bfebc73"
    ],
    "package_ndc": [
     "0591-0347-01",
     "0591-0347-05"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH"
    ]
   },
   "update_date": "11/19/2025",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Capsule",
   "presentation": "Microzide, Capsule, 12.5 mg (NDC 0591-0347-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "11/19/2025",
   "update_type": "New",
   "initial_posting_date": "11/19/2025",
   "package_ndc": "0591-0347-05",
   "generic_name": "Hydrochlorothiazide Capsule",
   "contact_info": "800-545-8800",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA020504"
    ],
    "brand_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "generic_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-0347"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "HYDROCHLOROTHIAZIDE"
    ],
    "rxcui": [
     "199903"
    ],
    "spl_id": [
     "b062bc7e-af92-4648-aed1-e02568313e21"
    ],
    "spl_set_id": [
     "a3eb7294-f913-434b-896c-da028bfebc73"
    ],
    "package_ndc": [
     "0591-0347-01",
     "0591-0347-05"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "0J48LPH2TH"
    ]
   },
   "update_date": "11/19/2025",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Capsule",
   "presentation": "Microzide, Capsule, 12.5 mg (NDC 0591-0347-05)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}